bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $4.11 million. The enterprise value is $4.99 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 18.26 million shares outstanding. The number of shares has increased by 50.37% in one year.
| Current Share Class | 18.26M |
| Shares Outstanding | 18.26M |
| Shares Change (YoY) | +50.37% |
| Shares Change (QoQ) | +9.94% |
| Owned by Insiders (%) | 30.95% |
| Owned by Institutions (%) | 8.20% |
| Float | 12.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | 0.43 |
| PB Ratio | 2.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.92.
| Current Ratio | 0.55 |
| Quick Ratio | 0.41 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -114.15 |
Financial Efficiency
Return on equity (ROE) is -290.85% and return on invested capital (ROIC) is -126.48%.
| Return on Equity (ROE) | -290.85% |
| Return on Assets (ROA) | -88.58% |
| Return on Invested Capital (ROIC) | -126.48% |
| Return on Capital Employed (ROCE) | -451.97% |
| Revenue Per Employee | $154,548 |
| Profits Per Employee | -$170,850 |
| Employee Count | 57 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 239.41 |
Taxes
In the past 12 months, BIAF has paid $16,673 in taxes.
| Income Tax | 16,673 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.04% in the last 52 weeks. The beta is 3.03, so BIAF's price volatility has been higher than the market average.
| Beta (5Y) | 3.03 |
| 52-Week Price Change | -90.04% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 35.32 |
| Average Volume (20 Days) | 2,335,306 |
Short Selling Information
The latest short interest is 289,273, so 1.58% of the outstanding shares have been sold short.
| Short Interest | 289,273 |
| Short Previous Month | 362,571 |
| Short % of Shares Out | 1.58% |
| Short % of Float | 2.29% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, BIAF had revenue of $8.81 million and -$9.74 million in losses. Loss per share was -$0.71.
| Revenue | 8.81M |
| Gross Profit | 3.03M |
| Operating Income | -9.64M |
| Pretax Income | -8.35M |
| Net Income | -9.74M |
| EBITDA | -9.03M |
| EBIT | -9.64M |
| Loss Per Share | -$0.71 |
Full Income StatementBalance Sheet
The company has $444,706 in cash and $1.33 million in debt, giving a net cash position of -$886,456 or -$0.05 per share.
| Cash & Cash Equivalents | 444,706 |
| Total Debt | 1.33M |
| Net Cash | -886,456 |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | 1.44M |
| Book Value Per Share | 0.08 |
| Working Capital | -1.55M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 34.41%, with operating and profit margins of -109.38% and -110.55%.
| Gross Margin | 34.41% |
| Operating Margin | -109.38% |
| Pretax Margin | -110.36% |
| Profit Margin | -110.55% |
| EBITDA Margin | -102.48% |
| EBIT Margin | -109.38% |
| FCF Margin | n/a |